Drug reimbursement contracts satisfy all parties involved when they achieve three goals: The first is patient access, the second is sustained revenue for the pharmaceutical company, and the third is budget management for the payer.

“A fair price is one that can satisfy both the seller and the buyer,” said So-young Lee, Director of Health Insurance and Assessment Service’s Pharmaceutical Performance Assessment Division. ”A fair price should guarantee transparency, R&D, production costs, and innovation.”

So, what kind of reimbursement agreement can satisfy all three conditions? Experts say that a reimbursement agreement based on RWD (real-world data) can be a good alternative.